AIDS. 2005 Nov 18;19(17):w7-28. doi: 10.1097/01.aids.0000189853.29064.a8.
This report summarizes the presentations and recommendations from a consultation held in Lausanne, Switzerland (26-28 August 2004) organized by the joint World Health Organization (WHO) - United Nations Programme on HIV/AIDS (UNAIDS) HIV Vaccine Initiative. The consultation discussed issues related to gender, ethnicity, and age in HIV vaccine research and clinical trial recruitment. A special focus of the meeting was the participation of women and adolescents in clinical trials. Also discussed were the experiences and lessons from various research programs, trials, and studies in different countries. Implementing the recommendations from this meeting will require prioritization and active participation from the research community, funders of research, local and national governments, non-governmental organizations, and industry, as well as the individuals and communities participating in clinical trials. This report contains the collective views of an international group of experts, and does not necessarily represent the decisions or the stated policy of the WHO. The contribution of the co-chairs (R. Macklin and F. Mhalu) and the rapporteurs (H. Lasher, M. Klein, M. Ackers, N. Barsdorf, A. Smith Rogers, E. Levendal, T. Villafana and M. Warren) during the consultation and in the preparation of this report is much appreciated. S. Labelle and J. Otani are also acknowledged and thanked for their efficient assistance in the preparation of the consultation and the report.
本报告总结了由世界卫生组织(WHO)-联合国艾滋病规划署(UNAIDS)联合开展的艾滋病疫苗倡议于2004年8月26日至28日在瑞士洛桑组织的一次磋商会的发言内容和建议。此次磋商会讨论了艾滋病疫苗研究及临床试验招募中与性别、种族和年龄相关的问题。会议的一个特别重点是妇女和青少年参与临床试验的情况。会上还讨论了不同国家各种研究项目、试验和研究的经验与教训。落实本次会议的建议需要研究界、研究资助者、地方和国家政府、非政府组织、产业界以及参与临床试验的个人和社区进行优先排序并积极参与。本报告包含了一个国际专家小组的集体观点,不一定代表世卫组织的决定或既定政策。非常感谢共同主席(R. 麦克林和F. 姆哈卢)以及报告撰写人(H. 拉舍、M. 克莱因、M. 阿克斯、N. 巴斯多夫、A. 史密斯·罗杰斯、E. 莱文德、T. 比利亚法纳和M. 沃伦)在磋商会期间以及编写本报告过程中的贡献。还要感谢S. 拉贝尔和J. 大谷在筹备磋商会和报告过程中提供的高效协助。